S'abonner

Prevalence and prognosis of left ventricular systolic dysfunction in asymptomatic diabetic patients without known coronary artery disease referred for stress single-photon emission computed tomography and assessment of left ventricular function - 16/08/11

Doi : 10.1016/j.ahj.2007.04.042 
Panithaya Chareonthaitawee, MD a, , Paul Sorajja, MD a, Navin Rajagopalan, MD a, Todd D. Miller, MD a, David O. Hodge, MS b, Robert L. Frye, MD a, Raymond J. Gibbons, MD a
a Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic and Mayo Foundation, Rochester, MN 
b Department of Biostatistics, Mayo Clinic and Mayo Foundation, Rochester, MN 

Reprint requests: Panithaya Chareonthaitawee, MD, Mayo Clinic, 200 1st St. SW, Rochester, MN 55905.

Résumé

Background

The prevalence and prognosis of reduced left ventricular ejection fraction (LVEF) in asymptomatic diabetic patients without known coronary artery disease (CAD) are not known.

Methods

We examined 1046 asymptomatic diabetic patients (age 60 ± 13 years, 69% male) without known CAD referred to a tertiary referral center for stress single-photon emission computed tomography (SPECT) and assessment of LVEF. Patients were stratified according to the presence of normal LVEF (≥50%), mildly reduced LVEF (35%-49%), or moderately/severely reduced LVEF (<35%). Single-photon emission computed tomographic images were classified as low, intermediate, or high risk based on the summed stress score (normal = 56). The mean follow-up was 5.3 ± 3.3 years.

Results

The prevalence of reduced LVEF was 16.7% (n = 175, mean LVEF 40.0% ± 7.7%). This group was older (63 ± 11 vs 59 ± 14 years, P = .005), had more peripheral arterial disease (45% vs 29%, P < .001), and had a higher prevalence of electrocardiographic Q waves (21% vs 9%, P < .001) than the group without reduced LVEF. Mean summed stress (44.8 ± 9.8 vs 51.7 ± 6.3, P < .001), summed reversibility (4.7 ± 5.0 vs 2.9 ± 4.5, P < .001), and summed rest scores (49.4 ± 7.2 vs 54.6 ± 3.1, P < .001) were significantly more abnormal in the reduced LVEF group. High-risk summed stress score was significantly more common in the reduced LVEF group (46% vs 16%, P < .001). Survival was significantly lower in patients with any reduction in LVEF compared with those without reduced LVEF (10-year survival, 29% vs 57%, P < .0001). By multivariate analysis, reduced LVEF was independently associated with increased mortality (adjusted χ2 = 6.26, P = .01).

Conclusions

In this population of asymptomatic diabetic patients without known CAD referred for stress SPECT, 1 in 6 patients had reduced LVEF. Most of these patients have intermediate-/high-risk SPECT scans. The annual mortality rates of the groups with and without reduced LVEF were 7% and 4%, respectively.

Le texte complet de cet article est disponible en PDF.

Plan


 Dr Chareonthaitawee was supported by a research grant from King Pharmaceuticals, Cary, NC; Dr Miller by research grants from Bristol-Myers Squibb, North Billerica, MA, and King Pharmaceuticals); and Dr Gibbons by a research grant from King Pharmaceuticals.
 Presented in part at the 54th Annual Scientific Session of the American College of Cardiology, March 6-9, 2005, Orlando, FL.


© 2007  Mosby, Inc. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 154 - N° 3

P. 567-574 - septembre 2007 Retour au numéro
Article précédent Article précédent
  • Connexin37 (GJA4) genotype predicts survival after an acute coronary syndrome
  • David E. Lanfear, Philip G. Jones, Sharon Marsh, Sharon Cresci, John A. Spertus, Howard L. McLeod
| Article suivant Article suivant
  • Sex differences in basal hemodynamics and left ventricular function in humans with and without heart failure
  • Peter R. Mitoff, Abdul Al-Hesayen, Eduardo Azevedo, Gary E. Newton, Susanna Mak

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.